security

drug

Genius Brands International Inc

This scumbag low life bad bad pos has no morals in him whatsoever.

Sadly only sinking 😞 scammer weasel andy is a pos

$GNUS everything runs and this pos stays stagnet because management has 0 respect from retail.

ANDY HEYWARD IS A COLOSSAL POS AMD GENIUS BRANDS DESERVES 0 RESPECT FROM SHAREHOLDERS FOR HOW WE HAVE BEEN TREATED FOR MORE THAN TWO YEARS!!!

$GNUS  
 
More than 2 fking yrs holding this pos leading by the scam artist Andy Heyward makes me sick to my stomach.

$GNUS  The Market is spiking  and this piece is still going down so just remember this the next time one of you are tempted to say that this POS is down because the market is down.

$GNUS soooo hoping for a January run, this shit is not for the faint of heart.

bear

I definitely could not sleep at night if I were a bear. 🌈

$GNUS there’s bear scat everywhere and they’re crapping BS

Is this going to turn into the biggest bear trap ever.. Omg???

They are worst than Full blown Bears here.

$GMBL $WISA $HLBZ $GNUS  shorts posts, ain’t even a raccoon acting as bear !, they don’t even know what to do with moms money 😂 some one made them hold a bag  , nothing

and the bears and know it alls---You&#39;re so concerned with squabbling for the scraps(or pennies) from Longshanks&#39; table(or Hedgefunds) that you&#39;ve missed your God-given right to something better!!

This Admin comes to me very stock bearish like.

though believe that the people who pay them are  even more obtuse than the trolls they hire.

Just because you are bitter at being bagholders doesn’t mean you should be so salty to the honest bears who understood to never trust Andy.

I reply to who I want to reply to, Bull or Bear so you are consistently just wrong.

joke

Is it that hard to admit your investment was trash because the company is trash?

$GNUS jokes aside this is legit shite company

This moron is 100% responsible for the ridiculous drop in sp and having his IR responded to many of us that company has no control of sp is a bunch of bs.

$GNUS what a f’king joke at this point.

life

$GNUS Andy!I hope you and your circle of liars suffer in this and the next life!

I hope Andy and his circle suffer in this life and the next!

Way to go Andy and the management- I hope u guys pay in this and the next life for lying to shareholders and profiting on our back!

$GNUS I’ve Never seen more so called men acting like cry babies on a daily basis in my life!!

$GNUS it is not Yoyo… get a life ! 👇🏽

What sort of low life mocks people, kicks them when their down. You.

$GNUS other than my baby MoMA this is the 2nd worst decision in my life was to buy this at $1.40 stuck for years pos die

Moreover, based on the Company’s current cash and investments in marketable securities, the Company has sufficient liquidity to support its ongoing operations and has no current plans to raise capital.

The have enough cash to last them for the next 1.5 years, no exposure to dilution and have 6 drugs in the pipeline.

$SAVA has the best Alzheimer’s drug in history - the other 2 I’m just trading .

share

$GNUS I have unwaveringly supported this stock from 2020 until now; building my portfolio to a high of 20k shares.

We remain fully committed to driving shareholder value and remain encouraged by the outlook for the business, including our brands, our distribution platforms, our recent acquisitions, and our increasing market share.

Hold your shares we will have our day to rise.

$GNUS A wonderful day to own shares of Genius Brands!

$GNUS in a few years from now gnus employees will be very happy with the share price

$GNUS for only $2500 I got over a million shares of KGKG and it seems to be doing way better than my GNUS that I have been holding for 3 years.

$GNUS wow really nice 8100 share order at 3.34 just now

$GNUS seems to be holding up well, glad I’m not disappointed in the value of my shares.

When i get my hands on more shares im moving to Beverly Hills!! !

nasdaq

Mawson Infrastructure (NASDAQ:MIGI) stock is jumping nearly 16% today.

The most undervalued play on Nasdaq, running into multiple catalysts, zero exposure to loss, with 3000%+ potential short term gains from current SP.

trading

We are consistency hitting profit with our trading strategy.

BiomX (NYSEMKT:PHGE) shares are getting a more than 18% boost in Friday morning trading.

FREE Trading Room via (Google Search)⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

$GNUS 19 trading days to to hit $1 for 10 straight days prior to Feb 28……looking strong!!! !

$GNUS started trading over 5 months ago and my account gained 300 percent lol.

but 1/2 daily volume in first trading hour is encouraging.

$GNUS 20 tradings left to hit a dollar and stay there for p straight days!!

$GNUS Not too shabby for 8 days of trading

Axsome Therapeutics Inc

executive

$AXSM This better be a joke or the CEO is getting it

If it does what it did yesterday I am going to lose my shit with the CEO for no good reason.

Resort to racist/sexist language to drive bears/shorts from public forums. 5.

Visions of tearful bears filled my dreams.

$AXSM  
 
Effectively, last Friday was bigly bear trap!

$AXSM Important to remember, we are in potentially the beginnings a brutal bear market.

action

Looks like the share price got ahead of itself - price action the past 2 days was very negative.

But, the action is very foolish and shortsighted, given what the insiders are doing with their stock options.

And this action was a rinse-and-repeat operation that shredded the shorts who had no choice

Steals families of memories &amp; family members suffer.

$AXSM DOW, S&amp;P, Russell, QQQ, XBI…it’s ALL down.

friend

Joon Lee -- Truist Securities -- Analyst 
 
&quot;. Great.

Guggenheim Securities Reiterates $AXSM with Buy, raises the price target to $105 from $80; in a good spot on the chart

Conclusion 73% of users had good results and for a MDD drug that is very good.

I haven’t felt this good in many years and it’s the only drug that worked&quot; 
 
&quot;.

The drug is fast-acting, so it could stand out from rivals.

I have treatment resistant depression and this is the first drug that has had an immediate mood-elevating effect on day 1 within 30 minutes of taking it.

There are many MDD generic drugs available.

though so we’ll see&quot; 
10 / 10 
 
behindblueeyes2 
December 5, 2022 
&quot;This drug is really helping me out and acted in less than 2 weeks.&quot; 
10 / 10

We alerted the BUY signal at $58.27 and we were able to close this one with profit at $60.86 ✅

Strong buy, IMO with BO potential growing.

BUY AZYO here while you can at $4.80 on its way to $15!

I still think it is a strong buy under $70. GLTY

news

It’s great news to see positive reviews from Veterans.

and we know how that turned out, so highly bullish news I guess!!

News on strong sales growth will occur as the year progresses, as this is built into the first full year of Auvelity sales.

I expect rapidly ramping sales, more transparancy on Ex-US exposure, and possibly some big surpising news items.

Based on last year, after a dip like we&#39;ve had the last 10 days, we will get unexpected good news that will pop us 35-40% within 2-4 weeks.

$AXSM people don’t read the 8-K for themselves, this is good news, today was/is just discounted shares.

It was followed up
With some really strong 
News. .

Some good news would be a great present 🥳

market

$SRPT $AXSM always outperform market during recession… safe haven

thid propably means that the share price can increase several days in a row when market conditions are fine 😎🤞

$AXSM Market psychology at its best right here.

$AXSM for a company to be successful, three critical elements are required: 
1. a competitive product 
2. a sizeable market 
3. an effective leadership team 
 
Imho, Axsome checks all three boxes.

$AXSM 2 Promising New Growth Stocks to Watch in 2023 
 
Axsome Therapeutics (AXSM 4.08%) actually beat the bear market last year.

$AXSM Good action for AXSM today in a tough market.

$AXSM this is holding well considering the market dump

$AXSM I feel very strongly that the volume in this stock will increase dramatically once the Markets open in the morning.

$AXSM Friday&#39;s holiday script report on scripts was very strong again, further establishing the market is showing satisfaction with Auvelity&#39;s effectiveness--the key question we need the market to answer.

SELLAS Life Sciences Group Inc

buying

$SLS  I wont be buying anymore shares until the CEO can show is company is worth at least 150m marketcap 
 
Look at the 3 year chart be warned the CEO is a scam artist and a liar

You are better off hoarding cash vs buying into a company where the staff sells free shares and does not deserve pay raises during a economic crisis/recession.

$SLS  No one should be buying in at these prices though.

$SLS SERIOUSLY STOP FUCKING RUNNING ALL THE BUYING OTC DARK POOL!!!

This MM is refusing to honor order flow, they are refusing to move the price higher when buying comes in, they are dictating price direction and that&#39;s not their fucking job.

HOW THE FUCK DID THEY JUST FILL 24k BUYING VOLUME AND NOT A SINGLE $.01 MOVE!!!!

but buying inflow and a 5K buy order and yet POS MM will not let it fucking go!! !

application

Gfh009 is a joke and will ruin this stock until 3d meds sees fda approval for aml gps.

16/16 
In all 3 Options GPs gets FDA approval due to QOL, venclexta, onureg, oralAz - all Cr1 salvage agents are highly toxic.

This concerns me, we get the dreaded not statistically relevant ruling from the FDA.

- OUTRIGHT LIE saying THEN 52 weeks - PURE BS 
- OUTRIGHT LIE saying THEN patients need to Die 
Co is now on RECord Reiterating 80 Events, patient deaths in Q1Q2 
That is the fda green light moment.

announcement

You fucked up and shorted NCI non dilutive funding announcement and patients living longer news.

$SLS they supposedly hired a lawyer fill time and this was never announced .

The shorts feeling the pain on their announcement.

$SLS For those predicting some big announcement from Sellas on the 14th at the Regal symposium, you are going to be terribly disappointed.

investor

What a freaking smack in the face to investors.

Angelos has intentionally screwed the long term investor.

$SLS I find it arrogant that SLS would even investors were concerned about their SIVB exposure.

but after doing an offering and the way the market is, the company should be giving some communication,  otherwise you are showing you really don&#39;t care about long term  investors,  personally  I&#39;m not impressed with the way it&#39;s been handled.

$SLS This is a JOKE and the JOKE is on the real investors ☹️

$SLS SLS investors have two problems now.

If you’re an experienced investor and you buy this scam, you deserve to lose you your investment.

$SLS No one should buy  in to this unless you are new investor.

They need to communicate and support their investors and shareholders.

Scary that I bought 2 years ago 9000 shares $6.50 average price to see this today just seems like he doesn’t care at all for investors why would he?

Way to go Mr. CEO  
JMP securities got your back!

$SLS Thank the Medical Doctor from SVB Securities.

I have concluded SLS are developing the best in a class of immunotherapy drug.

This drug has no serious toxicity issues and extends OAs.

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

They have the best in class &quot;CDK9 inhibitor&quot; (if that drug class even exists.

Be Holding as many as you can - the announcement will be coming any day from here on out and its worth an instant billion plus in Market value - Treating 20,000 patients each year, market comp drug pricing at $250K per.

patient

It reported positive outcomes in pleural mesothelioma patients, including:
Improved survival: Study patients lived around 11 months.

* Best Available Therapy offers 6-8 months of Overall Survival  
* All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival 
* All pooled Regal patients, BAT and Gps combined, is 16 months.

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

- Best available treatment 6-8 months of os.

- Cured GPS patients, continue to elongate the OS curve in Gps favor every day that goes by.

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

$SLS NCT update, nice…
They target 140 patients in 110 investigational sites.

$SLS With news on its way, the confidence built in the science, fear factor is gone.

$SLS No breaking news here regarding Sellas, and its well above my understanding,

$SLS good news, at the current rate and the ridiculous prices, in about a month you can buy this company for free.

My guess is that they generated ~3m revenue through the EAP, which would be really great news.

This is a rare opportunity that you know the news is grossly good(it convinced in investor(s)) and still have the chance to load and make 50 to 100% in .month or so.

plenty of upside if there is positive news.

$SLS they picked a great day for this news. lol

So much for this offering being good news.

Positive trial data/results supported with bullish news and sentiment! 4.

trial

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn&#39;t a deal with $mrk or $BMY or some other CPI BP  
--- That data is Best In Class - best in clinic, best in trial too.

The nation’s best means the O&#39;Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.

Top Stocks matching your search for "securities drug"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

GNUS

Genius Brands International Inc

-61.31%

$6.54 - $2.53

Mar, 13, 2023

Mar, 13, 2023

AXSM

Axsome Therapeutics Inc

-4.66%

$65.95 - $62.88

Feb, 27, 2023

Jan, 3, 2023

Divihomes is Now Live

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Nov, 30, 2022

Oct, 18, 2022

GNUS

Genius Brands International Inc

-61.31%

$6.54 - $2.53

Mar, 13, 2023

Mar, 13, 2023

Mar, 13, 2023

AXSM

Axsome Therapeutics Inc

-4.66%

$65.95 - $62.88

Feb, 27, 2023

Jan, 3, 2023

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Nov, 30, 2022

Oct, 18, 2022